Drug Profile
Research programme: small molecule therapeutics - European Molecular Biology Laboratory/Enamine
Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Enamine; European Molecular Biology Laboratory
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer